Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × Metronidazole × Clear all

NCT06356597 2026-02-24

Tislelizumab With Fruquintinib, Metronidazole, in Mismatch Repair-proficient or Microsatellite Stability, Advanced Colorectal Cancer: a Multicenter, Single Arm, Clinical Trial

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06728072 2026-02-09

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT04729322 2025-12-23

Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders

Phase 2 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT04264676 2020-11-25

Study of Oral Metronidazole on Postoperative Chemotherapy in Colorectal Cancer

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms